Global PD-L1 Biomarker Testing Market Poised for Growth at Over 9% CAGR, Reaching USD 1.58 Billion by 2033
The global PD-L1 biomarker testing market is surging, driven by the increasing demand for personalized cancer treatment and the rising burden of cancer worldwide. According [read full press release…]